Acute Porphyria Drug Database

Monograph

B01AA03 - Warfarin
Propably not porphyrinogenic
PNP

Rationale
Metabolised by CYP 2C but no data pointing to CYP-induction. Three references consider it safe.
Chemical description
Vitamin-K antagonist. Metabolized by CYP 2C9. No data pointing to CYP-induction. South African list: use. Kalman, Bonkowski: safe. Michael Moore: safe. C.Andersson; patient reports: tolerated (n=3)
IPNet drug reports
Uneventful use reported in 20 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes B01A / B01AA or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Marevan 5 mg comp. Aldocumar · ALDOCUMAR 1 mg COMPRIMIDOS · ALDOCUMAR 3 mg COMPRIMIDOS · ALDOCUMAR 5 mg COMPRIMIDOS Coumadin Coumadin · Marevan · Warfarin Marevan · Warfarin Orion · Warfarinnatrium 2care4 Aldocumar · Marevan · Marevan u/farge · Warfarin Orion · Warfarin Sodium rosemont Warfin Marevan Warfarin Teva Marevan · Marevan Forte · Warfarin Orion Orfarin · Warfarin-Grindeks Farin®
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙